Docetaxel: Medgend

Docetaxel FDA Approved Drugs

DOCEFREZ [Docetaxel^{C₄₃H₅₃NO₁₄3H₂O}]

20mg/vial (injection injectable)

80mg/vial (injection injectable)

Sun Pharma Global^{May 3, 2011}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

DOCETAXEL [Docetaxel^{C₄₃H₅₃NO₁₄3H₂O}]

120mg/6ml (20mg/ml) (injection injectable)

140mg/7ml (20mg/ml) (injection injectable)

160mg/16ml (10mg/ml) (injection injectable)

160mg/8ml (20mg/ml) (injection injectable)

200mg/10ml (20mg/ml) (injection injectable)

20mg/0.5ml (40mg/ml) (injection injectable)

20mg/2ml (10mg/ml) (injection injectable)

20mg/ml (20mg/ml) (injection injectable)

80mg/2ml (40mg/ml) (injection injectable)

80mg/4ml (20mg/ml) (injection injectable)

80mg/8ml (10mg/ml) (injection injectable)

Hospira Inc^{Jun 23, 2016}
Actavis Llc^{Apr 12, 2013}
Sandoz^{Jun 29, 2011}
Accord Hlthcare^{Apr 20, 2012}
Eagle Pharms^{Dec 22, 2015}
Dfb Oncology Ltd^{Jan 20, 2017}
Dr Reddys Labs Ltd^{Nov 5, 2014}
Teva Pharms Usa^{Sep 16, 2015}
Jiangsu Hengrui Med^{Feb 15, 2017}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

JEVTANA KIT [Cabazitaxel^{C₄₅H₅₇NO₁₄}]

60mg/1.5ml (40mg/ml) (iv (infusion) solution)

Sanofi Aventis Us^{Jun 17, 2010}

Treatment in combination with a corticoid such as prednisone of prostate cancer previously treated iwth docetaxel.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

TAXOTERE [Docetaxel^{C₄₃H₅₃NO₁₄3H₂O}]

160mg/8ml (20mg/ml) (injection injectable)

20mg/ml (20mg/ml) (injection injectable)

80mg/4ml (20mg/ml) (injection injectable)

Sanofi Aventis Us^{Apr 13, 2012}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

XTANDI [Enzalutamide^{C₂₁H₁₆F₄N₄O₂S}]

40mg (oral capsule)

Astellas^{Aug 31, 2012}

The treatment of patients with metastatic castration-resistant prostate cancer (crpc)..
The treatment of patients with metastatic castration-resistant prostate cancer who have previously received docetaxel.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

ZYTIGA [Abiraterone Acetate^{C₂₆H₃₃NO₂}]

250mg (oral tablet)

500mg (oral tablet)

Janssen Biotech^{Apr 28, 2011}

Use in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer who had received prior docetaxel chemotherapy.
Use in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer who have received prior chemotherapy containing docetaxel.
Use in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.

Ledgend of Medicine

MODERN MEDICINES

HOME REMEDIES

RANDOM DRUGS

RANDOM AILMENTS

Docetaxel FDA Approved Drugs